Long QT Syndrome Diagnosis and Management

Clinical Presentation and Diagnosis

The American Heart Association emphasizes that the primary purpose of syncope evaluation is to identify potentially life-threatening diseases such as Long QT Syndrome (LQTS), which can be fatal if missed, particularly in young patients with syncope and subsequent rhythm disturbance 1, 2
LQTS is a critical diagnosis to identify in young patients presenting with syncope, as it predisposes to life-threatening ventricular arrhythmias (torsade de pointes) and sudden cardiac death, with the European Heart Journal noting that supraventricular arrhythmias are less frequently implicated as causes of syncope than ventricular arrhythmias 1, 3, 4
The European Heart Journal notes that pre-excitation (Wolff-Parkinson-White syndrome) can cause syncope, but it occurs in only up to 20% of patients with supraventricular tachycardias and is less commonly the presenting feature compared to palpitations 4
Right bundle branch block alone does not predispose to dangerous arrhythmias or syncope unless associated with other conduction abnormalities, according to the European Heart Journal 5

Immediately measure the QTc interval on the ECG, as a QTc >0.44 seconds is diagnostic of LQTS, with QTc ≥0.50 seconds indicating higher risk, according to the American College of Cardiology and the American Heart Association 1, 2
The American Heart Association states that patients with inherited long QT who present with unstable ventricular arrhythmias should have electrocardiographic monitoring until stabilization 3

The American Heart Association recommends that patients with LQTS require continuous cardiac monitoring until LQTS is excluded or treated, and avoid QT-prolonging medications and correct electrolyte abnormalities 3, 4
Beta-blockers, particularly propranolol, are first-line therapy for LQTS and have been shown to be most effective in preventing ventricular arrhythmias, although they can cause bradycardia, which may paradoxically prolong QT further 4